📄 Cross-examination of Gary Sims (part 2) — Friday, November 15, 1996
Address:
C:\DEPT103\CIVIL\1996\NOV\15\CROSS-EXAMINATION-OF-GARY-SIMS.DOC
TRIAL
▲ Day 16 of 57

Cross-examination of Gary Sims (part 2)

Witness: Gary Sims
Examiner: Robert Blasier
Called by: Plaintiff • Date: Friday, November 15, 1996 • Utterances: 374
Defense attorney Robert Blasier cross-examined Gary Sims, a DNA analyst from the California DOJ, systematically attacking the reliability of the lab's PCR/DQ alpha typing results. The central thrust was that Sims applied inconsistent standards when interpreting faint dots on typing strips — calling a faint 1.3 dot on item 31 (Bronco console blood) a 'real allele' implicating Goldman, while dismissing similar faint 1.3 dots on positive controls, QC samples, and re-tests as mere 'cross-hybridization.' Blasier also highlighted the anomalously high DNA quantity in the back gate stain (item 117) compared to the Bundy drops, and pressed on the limits of the RFLP match window.
1 MR. BLASIER:

Thank you, Your Honor.

2 Q:

(BY MR. BLASIER) You said, Mr. Sims -- at the break, we were talking about windows. Do you recall that?

3 A:

Yes.

4 Q:

And your lab uses a window to -- because of the limitations of the technology and the limitations of your ability to really measure these fragments precisely, correct?

5 A:

Yes.

6 Q:

And what is the size of your window?

7 A:

The -- the window that we have is plus or minus 1.8 percent, for a total of 3.6 percent.

8 Q:

Mr. Sims can you see from here?

9 A:

Just slightly more of an angle, I can see it.

10 (Indicating to exhibit.)
11 Q:

If you need to come down, you can come down.

12 A:

That's fine.

13 Q:

So your window is 3 or 3.6 percent, correct?

14 A:

That's the total.

In other words, if two samples were to be declared a match, they would have to be no more than a total of 3.6 percent apart, and that would define the extremes.

15 Q:

Okay.

So hypothetically, a band that is -- if we talk about a 10,000 base-pair band, you would declare that to match to a band that is as small as 10,000 minus 360, right?

16 A:

Well, there's one technical glitch here, and that is that our match criteria only applied below 9,416 base pairs you're up at that high end where we don't have a match criterion. That's why we don't use those bands in the statistical calculations, either.

17 Q:

So you -- you've just ruled those out; you don't even measure those?

18 A:

We visually look at them -- that's important -- that's the first part of the process, to decide visually if they match.

We would do the sizing after that. They can be more at that high end because we don't have the match criteria that's the same up there.

19 Q:

Okay. Your cell markings go all the way up to 3,000 base pairs?

20 A:

I'm not aware of that. I don't know.

21 Q:

For our hypothetical, let's assume 10,000, an easy number to work with.

22 A:

Okay.

23 Q:

Under your match criteria, the lower end of what you would declare a match is 10,000 minus the 360 approximately, correct?

24 MR. LAMBERT:

Objection. I think that misstates the evidence.

25 Q:

3.6 percent, 10,000?

26 A:

Can I just do the . . .

27 Q:

Sure.

28 (Witness performs calculation.)
29 A:

Yes, that's correct.

30 Q:

What's that number?

31 A:

That would be -- that would be 9640.

32 Q:

And the upper end of that would be 10,000?

33 A:

Plus.

34 Q:

Plus 360?

35 A:

Yes.

36 Q:

And I can't reach -- (indicating to handwritten diagram).

THE COURT REPORTER: Excuse me. What number is that?

37 MR. BLASIER:

This is 2184.

38 Q:

(BY MR. BLASIER) So you would declare a match for any bands that your computer told you were within this range, correct, when you're comparing it to a band here?

39 A:

When -- yes, when we're comparing it to a band there, at that -- at that particular point, then we could go 3.6 percent in either direction for that particular band.

40 Q:

And you would agree, would you not, that in reality, if there is a single base-pair difference between your -- this one and this one, it's from different people, right?

41 A:

If -- Well, you would possibly see more like a 16 base pair, something like that.

It would be a different repeat. You know, there's a technical reason for that.

42 Q:

Right.

43 A:

Yes. Different people.

44 Q:

And you don't have the ability to measure it down to that tolerance, do you?

45 A:

That's correct.

46 Q:

Now, your window is a different size window from other labs, isn't it?

47 A:

Yes.

48 Q:

And Cellmark -- your testimony was approximately plus or minus 2.6 percent. We used 2.5 because the numbers are easier. It means 5 percent below and 5 percent above.

So you would agree, would you not, that under your window, if something fell outside of your range, you wouldn't call it -- you would say that it did not match; whereas, another lab with the same data might say it's a match?

49 A:

It -- well, again, part of the assessment, though, too, is the visual assessment when we see something at that level, say 3.6 percent -- I mean, I would be very suspicious that those two samples would match, just because it's so rare that unless there's some real change in the sample, that you would see that much of a shift.

50 Q:

Okay.

51 A:

That's an incredible shift. And so that's why we do so many of these probes, is to see that they line up all the way down, across all the Autorads.

52 Q:

You would agree that you allow yourselves this much of a tolerance in your measurements, don't you?

53 A:

We do on a single-band basis. And again, we would -- we would have to see that consistently through all the probes.

54 Q:

Okay. And a band -- two bands that your computer told you were two percent apart is treated just the same as -- just as good a match as two bands that your computer says are really the same, right?

55 A:

Well, when you when you look at it on the -- on the basis of a single band, that's correct.

But part of this whole assessment is looking at the entire profile across all the Autorads. And I would never expect to see a change of that sort of magnitude in one direction and then a change in the other direction of that sort of magnitude. That wouldn't happen.

56 Q:

Okay.

But you -- tell me, the most -- the highest number -- highest RFLP number for a stain consistent with Mr. Simpson was what?

Do you remember?

57 A:

No. I'd have to go through all the data to see what it is.

58 Q:

You had one that was a -- did you have a nine-probe match?

59 A:

Yes, I believe we did, on the rear gate and one of the sock stains.

60 Q:

Okay.

A nine-probe match means you're looking at 18 bands, correct?

61 A:

Well, it could be that there's a single-band pattern in one of those, but I think -- I think Mr. Simpson was a double-band pattern in all those loci, I think. That's my recollection.

62 Q:

So of those bands, can you tell me how many did your computer tell you were actually the same?

63 A:

Were exactly the same?

64 Q:

Yeah.

65 A:

I'd have to go through the data.

I doubt if any of them were exactly the same.

66 Q:

Okay.

So your computer told you that none of those bands were identical, correct?

67 A:

Well, I'm not sure on that. I'd have to check the data on that, that none of them were.

68 Q:

Well, to save you a little bit of time, isn't it true that in most of these cases, the computer tells you that the bands are not the same?

69 A:

Generally, there's a slight variation; that's correct.

70 Q:

You were asked about the back gate stain, 117. Do you remember those?

71 A:

Yes.

72 Q:

And we were talking about the quality of the DNA or the quantity of DNA in that back gate stain, correct?

73 A:

Yes.

74 Q:

And you were asked questions about the fact that drops that are picked up off the concrete might have different quantities of DNA than blood that is on a surface like the gate, correct?

75 A:

Yes. I would think the gate would be less absorbed. For example, Mr. --

76 Q:

Okay.

You tested DNA sample number 44, which was LAPD item number 51, correct?

Remember that?

77 A:

I'm sorry. Could you give they me those numbers again.

78 Q:

Yeah. LAPD item number 51.

79 A:

Okay.

80 Q:

And you gave that DNA sample number 44?

81 A:

Yes, that's correct.

82 Q:

And that was a stain from the front gate at Bundy, was it not?

83 A:

Yes.

I want to check the notes on that.

84 Q:

It might help you to know that was LAPD photo item number 116.

85 A:

Okay. Thank you.

Yes, that is our number 44, LAPD number 51, blood stain collected from the front gate.

86 Q:

That was collected on June 14, was it not, along with the Bundy drops?

87 A:

That's my understanding.

88 Q:

And that was the same kind of surface as 117 on the back gate that was collected three weeks later, correct?

89 MR. LAMBERT:

Objection. Lack of foundation.

90 THE COURT:

Sustained.

91 Q:

Let's assume hypothetically -- I mean, it's the same kind of gate surface as 117, isn't it.

92 MR. LAMBERT:

Same objection.

93 MR. BLASIER:

Do you know?

94 THE COURT:

If you know.

95 A:

I remember seeing some photographs and I think -- I think it looked somewhat similar. I don't remember if they're both white or what exactly -- if they're the same, but they're similar sort of metal surfaces, as I recall, painted metal surfaces.

96 Q:

Okay.

97 A:

There's that in my memory.

98 Q:

You're aware that 117 on the back gate wasn't collected until July 3 or thereabouts?

99 A:

That's my understanding, yes.

100 Q:

Now, you did testing on item 51 from the front gate. And the DNA in that sample was severely degraded, was it not?

101 A:

Yes, it was; the DNA was degraded on that sample.

102 Q:

And the DNA from 117 on the back gate was much, much higher in quantity, was it not?

103 A:

It was. Actually, the overall total quantity of human DNA was estimated to be about four times more on the gate, but the DNA on the -- on the front gate was degraded human DNA.

104 Q:

Okay.

Now -- and the amount of DNA on the rear gate, also, when you try to quantitate how much is there, again, these are your estimates, are they not?

105 A:

Yes, these are estimates. Some of them are based on slot blots for a human probe; some of them are just based on total yields of DNA.

106 Q:

And the back gate stain had more DNA than the Bundy drops and the Rockingham drops, correct, in the Rockingham driveway?

107 A:

Can you say that again? Which ones?

108 Q:

The Bundy drops and item number 6, which is a Rockingham drop?

109 A:

Had more DNA? I'm sorry.

110 Q:

At 117, had a lot more DNA than those, correct?

111 A:

It had about twice as much as one of the Rockingham drops.

KEY QUOTE
112 Q:

Okay. You remember we went through calculations in the criminal trial --

113 A:

Yes.

114 Q:

-- on quantity. And the estimate at that time was that number 6 -- that 117 had four times as much DNA as number 6. Do you remember that?

115 A:

Yes. I think when we did this, though, we did some kind of calculation where we looked at nanograms of DNA per milligram of swatch material, because all these samples were weighed.

But as far as the overall yield, the number 117 had about 1008 nanograms; whereas, the number 6, the Rockingham sample, had about 56 nanograms. So it was about twice as much on the rear gate as the Rockingham drop in terms of total DNA from all the swatches and that sort of thing.

That's one of the variations in these kinds of calculations, how these samples are collected and how concentrated the swatches are, how much variation there is among and within swatches.

116 Q:

And you calculate or calculated that item number 47, the first Bundy drop, that 117 had about 27 times as much DNA as 47, correct?

117 A:

Yes, on a nanogram per million gram, basis that's correct.

118 Q:

47 had an extremely small amount of DNA, did it not?

119 A:

Yes. It was -- it was a -- it was about 4 nanograms that we got out of it, 4.3 nanograms. Some of the other ones had less.

120 Q:

Okay. Bundy drop 48 had -- 117 had 45 times as much DNA as Bundy drop 4, did it not, approximately?

121 A:

Yes, again on a nanogram of DNA per million gram of swatch basis.

122 Q:

Bundy drop 17 had about 270 times as much DNA as Bundy drop 49?

123 A:

Yes, again, on that same basis.

124 Q:

Bundy drop 50, item 117, had about 50, 51 times as much DNA as Bundy drop 50, correct?

125 A:

Yes, again on that same basis.

126 Q:

Now, 52, you got more DNA out of 52 than in any of the other Bundy drops, correct?

You were able to do it?

127 A:

Excuse me.

No. On our -- there was a little difference here because our sample of 52 was a very small, little piece of the swatch. So on the basis of what we got out of that one swatch that we tested, because there were two that came back to us, we tested one of those and got about 3.6 nanograms out of that.

128 Q:

Okay.

So that's much, much more than 11 times. 117 is much more than 11 times of 52?

129 A:

I think, again, as we look at this on the basis of this nanograms per -- nanograms DNA per milligram of swatch, it's about -- that's about right, 11 times.

130 Q:

All right.

And you're aware, are you not, that 52, there was enough to get an RFLP result?

131 A:

Yes, that's my understanding, that's the sample that Cellmark got the RFLP result on.

We tested it for just the PCR markers, DQ alpha and D1S80.

132 MR. BLASIER:

Can we have the slide next in order, Phil.

MR. P. BAKER: I have.

133 MR. BLASIER:

Phil, 1118.

134 (The instrument herein referred to as chart entitled "Comparison of Swatched DNA Samples to 117" was marked for identification as Defendants' Exhibit No. 1118.)
135 THE COURT:

That's without the flashing.

MR. P. BAKER: Without the flashing.

136 (Indicating to TV screen.)
137 Q:

(BY MR. BLASIER) Now, item number 117, stain from the back gate, had a great deal of genetic information in it, didn't it?

138 A:

Yes, it did.

139 Q:

You didn't -- in processing item 117, you did not do anything to that stain that would have added EDTA to it, did you?

140 A:

I did nothing that would deliberately add it.

I mean, the samples -- we use EDTA as part of our chemicals in our laboratory on a routine basis. We weighed some of these swatches out on an analytical balance that was probably about, oh, three feet from a couple kilograms of EDTA, but we took measures to prevent any of that EDTA, certainly, from getting on any of those swatches.

So -- but when you do the actual extraction, then you do use EDTA as part of the chemicals. We left a portion of that sample by itself untested.

141 Q:

Well, then the use of EDTA, that's something new, is it not?

142 A:

Well, it's been in forensic laboratories for years. EDTA is a chemical.

143 Q:

In terms of your using it in these kinds of tests, that was a change of protocol that happened after your work in this case, was it not, based on an article that came out?

144 A:

No. I think you're confused here, because EDTA is a standard chemical used in any molecular biology laboratory.

145 Q:

But not put in these samples and not put in 117?

146 A:

It wouldn't be added to the swatches, but when you take the -- some of the swatches and do the extraction of the DNA, to get the DNA out of the blood stain, there's EDTA in the chemicals that you add to that blood stain. Okay.

147 Q:

Okay.

But you don't -- you don't put it in the swatch?

148 A:

No. I mean we would research a portion of the swatch that we don't add any EDTA to.

149 Q:

Okay.

Now, I put up the Bronco automobile board, which is -- I'm not sure what number it is. I think it's on the back. I think it's 131.

150 (Referring to Exhibit 293.)
151 Q:

One of your results from the center console, stain number 31, you indicated had a weak 4 and a very weak 1.3, correct?

152 A:

I remember that they were both weak. I don't remember the averb "very" being put on the 1.3, but it is present on the exhibit there.

153 Q:

There was a difference in intensity between the dots on the 4 and the 1.3, wasn't there?

154 A:

I think the 1.3 was a little bit weaker than the 4.

155 Q:

And even though they had different intensities, you concluded that that was consistent with Ronald Goldman, correct?

156 A:

That's correct.

157 Q:

And when you get a sample from evidence, you're going to get an equal amount of one allele as the other allele, correct?

158 A:

Well, one of the limitations of the test, for example, when you look at Mr. Goldman's reference blood, you don't see a perfect, absolute balance of those two alleles, and you can even see that in our graphs.

So they're balanced, what we call balanced, but they're not perfectly balanced. You might discern a slight difference, even though they're all the alleles from one individual.

MR. P. BAKER: The exhibit board is 293.

159 MR. BLASIER:

293.

160 Q:

(BY MR. BLASIER) That's another limitation of this technology, correct?

161 A:

Well, yes. The dots respond in a balanced fashion, but it's not what I would call a perfect balance.

162 Q:

Let me show you 2185.

Let me show it to you in person, make it easier.

These are some testing strips from your lab run out samples, among others, in the Bronco?

163 A:

Yes.

164 Q:

Okay.

165 (Witness reviews Exhibit 2185.)
166 Q:

(BY MR. BLASIER) Now, if we look at item 29, which is the stain from the steering wheel -- correct?

167 A:

Yes.

168 Q:

And we zoom in a little bit on it, you called this 4. That faint dot at 4, you called that as a real allele, correct?

169 A:

Yes, we did.

170 Q:

And you also -- I think you testified on direct that you're not going to rule out that there might be a 1.3 there, as well.

Did you say that?

171 A:

Excuse me. I don't see a 1.3 at all on the strip.

What I'm saying is that I couldn't absolutely rule out the possibility that that weaker DNA -- this is a mixture, right? This is a mixture. And I couldn't absolutely rule out the possibility that there was an allele from a second individual who has a 4 dot, but who also might have another dot that is just not showing up in that sample.

172 Q:

So that would be even much less than a hint, would it not? It's not even there?

173 A:

It's -- well, the point of that is that this is a very technical issue and it revolves around the fact that the main type is a 1.1, 1.2, and that there are similarities between those alleles with this 1.3 allele, such that when we do the PCR amplification, potentially we could lose the 1.3 compared to the 4.

174 Q:

There's no 1.3 there?

175 A:

There is no 1.3.

176 Q:

But you're not ruling out that that's a type 1.3, 4, are you?

177 A:

I'm -- this is a very difficult thing to explain for me.

178 Q:

Yes?

179 A:

What I'm saying is, I could not rule out the possibility that there was a weaker contribution; therefore a 1.3, comma 4 individual.

I certainly don't think there's anything in that sample that says, of course, that's what happened. I'm not saying that at all. Because, for example, you could have a second individual who's a type 4, 4 or a second individual who is a 1.1, 4 or a 1.2, 4. There's a lot of possibilities there.

So when I see this kind of sample, what it tells me to do is, let's look at some other markers, get some additional data.

180 Q:

This is completely consistent with a contributor who is a 4, comma 4?

181 A:

Absolutely.

182 Q:

And that doesn't match anybody that you know of in this case, correct?

183 A:

That's correct.

184 Q:

That's unambiguous, isn't it? That's an unambiguous interpretation of this, is it not?

185 A:

Well, I think that is one interpretation, and it's certainly a reasonable interpretation.

186 Q:

Now, the dot here at number 4, is that a hint, a trace, weak, very weak? How do you describe it?

187 A:

That's a weak dot.

But the other thing that's important when you're looking at these dots is, you look within one of these strips -- in other words, you study this strip horizontally, you don't go up to the one above it, you don't go down to the one below it. And if you look at this particular strip we are amplifying, I believe, in this case, in this sample, on the order of about 400 picograms, as I recall, of DNA, which is an extremely minute amount of DNA.

And it's reflected in the fact that the dot that's to the right of the letter C is also very weak. And so what we do on any given strip is, we score the dots in relationship to that C dot.

So in this case, that C dot was present. It was weak; we called the 4 dot at the same level as the C dot. Whereas, if you look at the right and see the 1.1 dot, you see that is greater than the C dot.

188 Q:

But that 4 dot, you said, is a real allele and it's an allele, and it's a very faint dot?

189 A:

It's a real allele.

One of the things about this system is that, when you have a nominal, what we call a nominal dot is those dots to the left, that those are definitely real dots, and you can see them.

190 MR. BLASIER:

Do you want to take that down?

191 (Indicating to TV screen.)
192 Q:

(BY MR. BLASIER) Now, on the Bronco (indicating to Exhibit 293) -- on the Bronco, all of the stains that have the lower numbers, you're aware, were collected on June 14, correct?

193 A:

That's my understanding, that those were collected on the 14th.

194 Q:

And the only sample that you say is consistent with any blood from either of the victims is number 31, correct?

195 MR. LAMBERT:

Objection. Misstates the evidence, Your Honor. Number 33, as well.

196 MR. BLASIER:

33?

197 MR. LAMBERT:

33.

198 MR. BLASIER:

I don't see a 33.

Oh, all right.

199 Q:

(BY MR. BLASIER) This is a sample from the carpet inside the car, correct?

200 A:

That's my understanding.

201 Q:

That's 33, which I think is also 293; is that correct?

202 A:

Yeah.

203 Q:

And our number is 29, I believe.

Yes.

When that fiber was actually taken off the carpet, it was given the number 293, correct?

204 A:

As I understand it, the carpeting material was collected on the 14th, and then later it's given a number of 293.

I don't -- I don't know exactly the history there.

205 Q:

Okay.

The actual sample here on the carpet that the fibers -- that were taken off the carpet and then tested, that wasn't done until much later than June 4; is that your understanding?

206 A:

That's my understanding, yes.

207 Q:

All of the -- all of the other ones with the low numbers were done on June -- collected on June 14, correct?

208 A:

That's my understanding, yes.

209 Q:

And the only one of those that indicates the contents with either of the victims is number 31, correct?

210 A:

That's correct.

211 Q:

What is the -- what is the function of a positive control?

212 A:

A positive control is used to evaluate if the test is working properly.

213 Q:

And a positive control is known DNA, you know, what the type is going in, and you hope to see the same type on your testing strip, right?

214 A:

Yes.

215 Q:

And if you don't, that indicates a problem, doesn't it?

216 A:

Well, it depends on how severe the irregularity is.

217 Q:

Well, the tests are designed so that the positive controls come out the same type that they are known to be, correct?

218 A:

Yes.

219 Q:

And if they don't, that indicates something, doesn't it?

220 A:

Yes.

221 Q:

It indicates that there might be contamination, correct?

222 A:

That's a possibility, yes.

223 Q:

It indicates there might be cross-hybridization?

224 A:

Yes.

225 Q:

Now, cross-hybridization is something that happens when you put too much DNA in the sample, correct?

226 A:

That's one of the possibilities.

Also, if hybridization conditions are such that they're a little bit off, you could get some cross-hybridization from that, too.

227 Q:

When you say "a little bit off," you mean a little different than what the manual says to do?

228 A:

Well, they may be off by, say, a degree or something like that in temperature, something like that, but just slightly, slightly off.

229 Q:

But that can be a very important difference, can it not, Mr. Sims?

230 A:

I'd say anything more than a degree could be significant, yes.

231 Q:

So the test is designed, if you do it precisely the way the manual says to do it, you should not get cross-hybridization, correct?

232 (No verbal response.)
233 Q:

Isn't that correct?

234 A:

No, I'd say that's not correct. It is a matter of degree.

In our laboratory, you will sometimes see traces of cross-hybridization, and you can still understand that as being cross-hybridization; it doesn't change the types.

235 Q:

But it can also be contamination, can it not?

236 A:

You always have to be concerned with contamination. That's why you run a lot of these negative strips that have no DNA.

237 Q:

Okay.

When you ran the sample for items 30 and 31 from the Bronco console, you ran a positive control, did you not?

238 A:

Well, excuse me. I believe these were actually run by Renee Montgomery when the typing was done on the 30 or 31.

239 Q:

But it's done in your lab?

240 A:

Yes.

241 Q:

You've seen this board before, have you not?

242 A:

I believe I have, yes.

243 Q:

And this is Criminal 1279.

The above control in that run showed up a very faint 1.3 dot, did it not?

244 A:

On which? I can't quite see.

245 Q:

You can step down, if you like.

The positive control.

246 (Referring to Exhibit entitled Bronco console stains collected 6/14/94.)
247 A:

No; that was negative, if I'm reading the right set.

Which date is this?

248 Q:

When you ran 30 and 31.

249 A:

Yes. I'm sorry. I'm looking at the right page now.

There was -- there was what was called a hint of that 1.3 dot there.

250 Q:

You can see it; it's very faint, but it's there, isn't it?

251 A:

I think you can see something there, yes.

252 Q:

That's one of the shortcomings of this test, trying to make these kinds of assessments of whether there's even a dot there, isn't it?

253 A:

Well, the shortcoming is when one tries to overinterpret these results, clearly one can see what the dot pattern is.

254 Q:

Okay.

The positive control is a type 1.1, 4 it has no 1.3 in it?

255 A:

That's correct.

256 Q:

That's an indication that either contamination or cross-hybridization occurred, correct?

257 A:

I would say cross-hybridization is most likely due to the fact that the other controls, the negative controls, are all negative.

258 Q:

Mr. Sims, can it -- it can be contamination, as well, can it not?

259 A:

It could be, yes.

260 Q:

What is a QC sample?

261 A:

A quality control sample. We have QC samples. These are samples that the analyst takes and processes at the same time as the evidence samples are being processed.

And those samples are blind to the analyst. The analyst doesn't know what the correct results are.

262 Q:

But you know -- I'm sorry?

263 A:

Well, we did something like 20-some of those in this particular case, and we got them all right.

264 Q:

QRC -- you got them all right.

QC 816, what was the correct type to QC 816?

265 A:

That was a 1.2, 1.2.

266 Q:

But you got a 1.1 and a 1.3, didn't you?

267 A:

There were hints of those dots, yes, that was stained.

268 Q:

You can't explain a 1.1 by cross-hybridization, can you?

269 A:

There can be some cross-hybridization, but it's more likely to be, more like what we call DX amplification.

270 Q:

This is another artifact that we're just going to say it's not DNA?

271 A:

You have to be concerned with that; you have to realize that this can show up in these typing results; that's why you don't want to interpret those very faint dots.

272 Q:

Let's look at LAPD item number 31.

273 A:

Okay.

274 Q:

This has a very faint 1.3 dot, does it not?

275 A:

I think that one's different.

276 Q:

You think it's different. Okay.

You called this one a real allele, did you not?

277 A:

Well, I did.

278 Q:

Okay?

279 A:

Ms. Montgomery did.

280 Q:

Mr. Sims, thank you.

You didn't?

281 A:

I did.

282 Q:

Whereas, the 1.3 here and here, you said we're going -- those were okay; that's not DNA; we pass the test, right?

283 A:

I think on this particular set of strips, that the controls were such that --

284 Q:

Mr. Sims --

285 MR. LAMBERT:

Your Honor, I'd like to ask him --

286 THE COURT:

He's he trying to answer your question, Mr. Blasier.

287 MR. BLASIER:

My question had called for a yes or no.

288 THE COURT:

I don't think so. You said he passed the test. He's a trying to explain to you what he passed.

289 MR. BLASIER:

Let me withdraw the question.

290 Q:

(BY MR. BLASIER) You didn't run it over again, did you?

291 A:

No, we did not.

292 Q:

Even though you got hints or traces or whatever you want to call them, of alleles that shouldn't be there, correct?

293 A:

That's correct.

294 Q:

Thank you.

295 A:

Yes.

296 Q:

Now, LAPD item 30, there's a dot at 1.3 there, as well, correct?

297 A:

Is this is now what LAPD item?

298 Q:

30.

299 A:

Which is our item -- is that 17?

300 Q:

I'm not sure what your number is.

301 A:

Let me check that.

Yes, that's our item 17.

302 Q:

Okay.

Did you call that an allele?

303 A:

No, that was considered too faint to be considered an allele.

304 Q:

Okay.

Now, development time out here.

This figure represents the lengths of time that you allowed these strips to soak in the substance that has the DNA, correct, to develop the dots?

305 A:

Well it's a color development. At that point, the DNA is -- has already come and gone, at that point there. Then there's a color development phase that goes on.

306 Q:

And in fact, the lengths of time that you use to develop these things can affect how intense the dots are, can't they?

307 A:

Well, once you get to about 20 minutes, there's not much change after that.

I mean there -- most of this result takes place within the first five or ten minutes. But in our laboratory, we let them go from 20 to 30 minutes.

308 Q:

There are differences, are there not, with different development treatment times in terms of the intensity of the dots?

Isn't there?

309 A:

I think once you get out to 25 minutes, you're very close to a plateau that's not going to change significantly.

310 Q:

There was a paper that came out not too long ago that showed that if you let these develop more than 20 minutes, you could have some dots that actually disappear, correct? Particularly from the polymarker system?

311 A:

That polymarker, I don't recall seeing that in the DQ alpha literature.

312 Q:

Do you recall a change in protocol being made in the DQ alpha, as well as the polymarker testing, because of that phenomenon?

313 A:

No, not in our laboratory. I don't -- I don't know of that.

314 Q:

Okay.

315 MR. LEONARD:

Do you have another board, Bob?

316 MR. BLASIER:

Yeah. Let's actually keep that one.

Put this one up.

317 (The instrument herein referred to as "Bundy Blood Drop, LAPD item 52, DOJ Typing."s was marked for identification as Plaintiffs' Exhibit No. 1281.)
318 MR. LEONARD:

Can you see this?

319 GARY SIMS:

Yes.

320 Q:

(BY MR. BLASIER) This is board number 1281. And these are testing strips for Bundy drop number 52, correct?

321 A:

Yes; that's the first time that 52 was tested.

I did a retest on that, also.

322 Q:

And the bottom one is the retest.

You want to take a look at that?

You rehybridized it?

323 A:

Yes, that's it.

324 Q:

Okay.

Now, 52 is a Bundy blood drop that you have said is consistent with O.J. Simpson and only O.J. Simpson, correct?

325 A:

Well our -- our testing was only DQ alpha and D1S80. It was the RFLP testing was done and Cellmark.

326 Q:

Your testing -- your conclusion was that it's consistent with O.J. Simpson and not either victim, or not some third party with a different type, correct?

You call that as a 1.1, 1.2?

327 A:

Well, among the three principals; that's correct

328 Q:

The 1.3 dot lit up on that strip, as well, did it not?

329 A:

Yes, it did.

330 Q:

You decided that's not DNA, correct?

331 A:

Well, I --

332 Q:

Isn't that correct --

333 A:

I made that --

334 Q:

-- Mr. Sims?

335 A:

No, because I did a retest on that.

336 Q:

This test strip, you said there's no 1.3 DNA in there, correct?

337 A:

Once I did the retest, I was convinced that it was cross-hybridization.

338 Q:

The retest also showed a 1.3 dot, did it not?

Very faint, but it's there, isn't it?

339 A:

I think -- I thought I saw something on that one that I called -- I guess you say it was very faint traces in the wording, but there's barely something there, yes.

340 Q:

Mr. Sims, isn't it accurate that in deciding these faint dots, you interpret them in a way that helps the side that you're working for?

KEY QUOTE
341 A:

No, I don't think so.

342 Q:

You don't think so?

343 A:

No.

344 Q:

So, picking up the other board, board 1279, the 1.3 dot that you said was real and the one on the other board which is not real, they are very similar in intensity, are they not?

345 A:

I would say that they are similar, yes.

KEY QUOTE
346 Q:

Thank you.

Now, you also, as you said before, did your own typing on the victims' reference samples, did you not?

347 A:

Yes.

348 Q:

And again, this was from the -- from the cards, not from -- you weren't sent the reference file, correct?

349 A:

That's correct.

These victims' samples relate to the swatches that we tested.

350 Q:

Looking at board 1275, isn't it true, Mr. Sims, that you found in Nicole Brown Simpson's reference sample, a possible 1.3 allele and a possible 1.2 allele?

351 A:

I'll have to look at my notes on that.

I identified a trace in the 1.2 dot and what I call a faint trace, which is a weaker result, in the 1.3.

352 Q:

Either of those could have come from Nicole Brown Simpson, correct?

353 A:

Well, as far as I know, no. She's a 1.1, 1.1.

354 Q:

And the only source among the people that have a 1.2 is O.J. Simpson, correct?

355 A:

Of those individuals.

356 Q:

Correct?

357 A:

Yes, that's correct.

358 Q:

And one Goldman's sample, you also found an indication of a possible 1.2 and a 1.3 -- I'm sorry -- and a 1.3?

359 A:

No.

360 Q:

I'm sorry. 1.1?

361 A:

Yes. In the 1.1, there was what we call a faint trace in the 1.1.

362 Q:

The only source among these three people of a 1.1 and a 1.2 in Mr. Goldman's reference sample is O.J. Simpson, correct?

363 A:

Well, the 1.1 is Nicole Brown's type, also.

364 Q:

Could this have come from either, consistent with either, correct?

365 A:

Well, I mean, that's a very hypothetical type of question, I think.

366 Q:

This is the result you reported, is it not?

367 A:

But --

368 Q:

Is it not?

369 A:

I'm looking at the photograph.

And clearly, I -- I -- perhaps we should pass this around to the jury -- but these dots are extremely faint, and I don't think they're necessarily representative of any true alleles showing up.

These look like the types that you see from cross-hybridization or the DX phenomenon that I mentioned.

370 Q:

I'm sorry. We'll call these "not real," right?

371 A:

Well, I don't believe these are the real alleles, and I think --

372 Q:

Thank you.

373 A:

If you look at the photo, you can see that.

374 THE COURT:

Let's take ten minutes.

Temperature

devastating

Key Quotes (5)

Robert Blasier
Isn't it accurate that in deciding these faint dots, you interpret them in a way that helps the side that you're working for?
The central credibility attack of the examination — accusing Sims of result-driven interpretation rather than objective science.
Gary Sims
I would say that they are similar, yes.
Sims concedes that the faint 1.3 dot he called a 'real allele' (item 31) and the faint 1.3 dots he dismissed as cross-hybridization are similar in intensity — the admission Blasier was building toward the entire examination.
Gary Sims
I doubt if any of them were exactly the same.
Sims acknowledges that in a nine-probe RFLP match, the computer likely found no bands that were truly identical — only bands within the 3.6% window — undermining the intuitive strength of the match.
Gary Sims
It had about twice as much as one of the Rockingham drops... the number 117 had about 1008 nanograms; whereas, the number 6, the Rockingham sample, had about 56 nanograms.
Quantifies the striking discrepancy between the back gate stain and the other blood drops — a key pillar of the defense's planted-evidence theory.
Robert Blasier
I'm sorry. We'll call these 'not real,' right?
Sarcastic encapsulation of Blasier's theme: that Sims has a habit of labeling inconvenient dots as artifacts.

Evidence (9)

Defendants' 2184
Handwritten diagram illustrating the 3.6% RFLP match window
introduced and used for calculation during testimony
Defendants' 1118
Chart entitled 'Comparison of Swatched DNA Samples to 117' showing DNA quantity comparisons between the back gate stain and Bundy/Rockingham drops
introduced
Exhibit 293
Bronco automobile board showing PCR typing results for Bronco stains
discussed; used to establish that only item 31 (and 33) showed victim-consistent types among June 14 samples
Defendants' 2185
Physical testing strips from DOJ lab runs on Bronco samples, including item 29 (steering wheel) and item 31 (console)
reviewed by witness; used to challenge interpretation of faint 4 dot and missing 1.3
Criminal 1279
Bronco console stains collected 6/14/94 — testing strips showing positive control with unexpected faint 1.3 dot
discussed; Blasier used to demonstrate positive control irregularity
Plaintiffs' 1281
Testing strips for Bundy drop item 52, DOJ typing (initial and retest)
discussed; Blasier pointed out faint 1.3 dot appeared on both the original and the retest, yet Sims dismissed both as cross-hybridization
+ 3 more

Notable Exchanges (4)

Robert BlasierGary Sims
Blasier built methodically to his core point: Sims called a faint 1.3 dot on item 31 (Bronco console, implicating Goldman) a 'real allele,' but called nearly identical faint 1.3 dots on positive controls and QC samples 'cross-hybridization.' Sims conceded the dots were 'similar in intensity.'
devastating
Robert BlasierGary Sims
Blasier walked Sims through the DNA quantity disparities between item 117 (back gate, ~1008 nanograms) and individual Bundy drops — some up to 270 times less DNA — implying the back gate stain was anomalous and potentially planted.
strategic
Robert BlasierGary Sims
Blasier pressed Sims on the RFLP match window: that no bands in the nine-probe match were actually computer-identical, only within the 3.6% tolerance, and that two percent separation is treated identically to a true match.
technical/methodical
Hiroshi FujisakiRobert Blasier
Fujisaki intervened when Blasier cut off Sims mid-answer: 'He's trying to answer your question, Mr. Blasier.' Blasier withdrew the question.
procedural

Credibility Attacks (2)

⚔ Gary Sims
inconsistent interpretation / bias
Blasier demonstrated that Sims applied different standards to visually identical faint dots depending on which interpretation favored the prosecution: a faint 1.3 on item 31 was a 'real allele,' while nearly identical faint 1.3 dots on positive controls, QC sample 816, and the Bundy drop 52 retest were dismissed as cross-hybridization or artifacts. Sims admitted the dots were 'similar in intensity.'
⚔ Gary Sims
quality control failure
QC sample 816, which should have typed as 1.2, 1.2, showed unexpected 1.1 and 1.3 hints. Blasier noted this could not be explained solely by cross-hybridization, and that the tests were not re-run despite these anomalies.

Witness Demeanor

(Witness performs calculation.)
(Witness reviews Exhibit 2185.)

Objections

4 objections (2 sustained, 0 overruled)
Proceeding 8278 • 374 utterances • Plaintiff witness
Civil Trial
Department 103
⚖️ Start
📂 NOV 15, 1996 📄 Cross-examination of Gary Sims
NOV 15, 1996 KRT DvH TD